Norman Franke

812 total citations
31 papers, 472 citations indexed

About

Norman Franke is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Norman Franke has authored 31 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Hematology and 11 papers in Molecular Biology. Recurrent topics in Norman Franke's work include Multiple Myeloma Research and Treatments (14 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers) and Cancer Research and Treatments (4 papers). Norman Franke is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers) and Cancer Research and Treatments (4 papers). Norman Franke collaborates with scholars based in Canada, United States and Germany. Norman Franke's co-authors include Donna Reece, Suzanne Trudel, Vishal Kukreti, Andrew Winter, Christine Chen, Joseph Mıkhael, Esther Masih‐Khan, Rodger E. Tiedemann, Víctor H. Jiménez‐Zepeda and Michael Crump and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Norman Franke

30 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norman Franke Canada 13 257 193 181 113 63 31 472
R. Champlin United States 6 162 0.6× 114 0.6× 114 0.6× 133 1.2× 70 1.1× 8 398
Nahıde Konuk Türkiye 12 347 1.4× 110 0.6× 189 1.0× 88 0.8× 77 1.2× 35 456
Masatoshi Sakurai Japan 13 204 0.8× 105 0.5× 118 0.7× 93 0.8× 64 1.0× 69 497
Ernesta Audisio Italy 12 174 0.7× 81 0.4× 159 0.9× 93 0.8× 37 0.6× 36 402
José L. Ochoa-Bayona United States 9 210 0.8× 110 0.6× 168 0.9× 48 0.4× 53 0.8× 40 371
Kun Soo Lee South Korea 12 287 1.1× 70 0.4× 98 0.5× 71 0.6× 126 2.0× 43 449
Alfredo Molteni Italy 13 191 0.7× 73 0.4× 85 0.5× 129 1.1× 30 0.5× 37 480
Elham Askari Iran 10 321 1.2× 252 1.3× 345 1.9× 40 0.4× 115 1.8× 29 651
María Collado Spain 13 135 0.5× 209 1.1× 67 0.4× 112 1.0× 79 1.3× 17 488
A. Insunza Spain 9 163 0.6× 82 0.4× 80 0.4× 60 0.5× 44 0.7× 24 366

Countries citing papers authored by Norman Franke

Since Specialization
Citations

This map shows the geographic impact of Norman Franke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman Franke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman Franke more than expected).

Fields of papers citing papers by Norman Franke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman Franke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman Franke. The network helps show where Norman Franke may publish in the future.

Co-authorship network of co-authors of Norman Franke

This figure shows the co-authorship network connecting the top 25 collaborators of Norman Franke. A scholar is included among the top collaborators of Norman Franke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman Franke. Norman Franke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mokhtari, Sepideh, Jeffrey A. Silverman, Kayla Reid, et al.. (2021). Transverse myelitis after anti‐CD19 directed CAR T cell therapy for relapsed large B cell lymphoma. SHILAP Revista de lepidopterología. 3(1). 223–227. 10 indexed citations
2.
Atenafu, Eshetu G., Rosanne St. Bernard, Esther Masih‐Khan, et al.. (2019). Toxicity and survival outcomes of autologous stem cell transplant in multiple myeloma patients with renal insufficiency: an institutional comparison between two eras. Bone Marrow Transplantation. 55(3). 578–585. 18 indexed citations
3.
Butler, Marcus O., Luisa Bonilla, Norman Franke, et al.. (2019). Effect of minimal lymphodepletion prior to ACT with TBI-1301, NY-ESO-1 specific gene-engineered TCR-T cells, on clinical responses and CRS.. Journal of Clinical Oncology. 37(15_suppl). 2537–2537. 3 indexed citations
4.
5.
Reece, Donna, Suzanne Trudel, Norman Franke, et al.. (2013). Oligoclonal and monoclonal bands after single autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survival. Leukemia & lymphoma. 55(10). 2284–2289. 14 indexed citations
6.
Puig, Noemí, Melania Pintilie, Tara Seshadri, et al.. (2011). High-dose chemotherapy and auto-SCT in elderly patients with Hodgkin's lymphoma. Bone Marrow Transplantation. 46(10). 1339–1344. 25 indexed citations
7.
Jiménez‐Zepeda, Víctor H., Joseph Mıkhael, Andrew Winter, et al.. (2011). Second Autologous Stem Cell Transplantation as Salvage Therapy for Multiple Myeloma: Impact on Progression-Free and Overall Survival. Biology of Blood and Marrow Transplantation. 18(5). 773–779. 72 indexed citations
8.
Franke, Norman, Andrew Winter, Donna Reece, et al.. (2010). Light Chain Deposition Disease: Impact of Stem Cell Tranplant on Hematological Response Achievement.. Blood. 116(21). 4600–4600. 2 indexed citations
9.
Puig, Noemí, Melania Pintilie, Tara Seshadri, et al.. (2010). Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma. Haematologica. 95(9). 1496–1502. 12 indexed citations
10.
Franke, Norman, Diego Delgado, Andrew Winter, et al.. (2010). High-Dose Melphalan for AL Amyloidosis: The Importance of Case Selection to Improve Clinical Outcomes. Blood. 116(21). 2403–2403. 5 indexed citations
11.
Mıkhael, Joseph, A. Keith Stewart, Christine Chen, et al.. (2009). Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy in Patients with Relapsed Multiple Myeloma.. Blood. 114(22). 1217–1217. 3 indexed citations
12.
Kumar, Deepali, Atul Humar, Agron Plevneshi, et al.. (2008). Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplantation. 41(8). 743–747. 72 indexed citations
13.
Seshadri, Tara, Khalil Al‐Farsi, Julie Stakiw, et al.. (2008). G-CSF-stimulated BM progenitor cells supplement suboptimal peripheral blood hematopoietic progenitor cell collections for auto transplantation. Bone Marrow Transplantation. 42(11). 733–737. 5 indexed citations
14.
Trinkaus, Martina, Stephen E. Lapinsky, Michael Crump, et al.. (2008). Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit. Bone Marrow Transplantation. 43(5). 411–415. 36 indexed citations
15.
Mıkhael, Joseph, A. Keith Stewart, Christine Chen, et al.. (2004). Outcome after Second Autologous Stem Cell Transplantation as Salvage Therapy in Patients with Relapsed Multiple Myeloma.. Blood. 104(11). 943–943. 5 indexed citations
16.
Hirji, Zahir, Michael Crump, Norman Franke, et al.. (2003). Contamination of Bone Marrow Products with an Actinomycete ResemblingMicrobacteriumSpecies and Reinfusion into Autologous Stem Cell and Bone Marrow Transplant Recipients. Clinical Infectious Diseases. 36(10). e115–e121. 14 indexed citations
17.
Mollee, Peter, Ashutosh Wechalekar, Denise Pereira, et al.. (2003). Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome. Bone Marrow Transplantation. 33(3). 271–277. 47 indexed citations
18.
Wehrmann, Wolfgang, Uwe Reinhold, Sylvia Kukel, et al.. (1990). Selective Alterations in Natural Killer Cell Subsets in Patients with Atopic Dermatitis. International Archives of Allergy and Immunology. 92(3). 318–322. 25 indexed citations
19.
Kühl, Jörn‐Sven, et al.. (1989). Cytokines and pancreatic cancer. Sensitivity of xenotransplants of predominantly pancreatic carcinomas to rIFN-gamma and rTFN-alpha in nude mice.. PubMed. 4(3). 303–19. 5 indexed citations
20.
Klapdor, R, et al.. (1989). Combined Therapy of Xenografts of Human Pancreatic Carcinomas With rTNF-α and Mitomycin C. Oncology Research and Treatment. 12(3). 143–147. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Champlin Breakdown of academic impact, for papers by Nahıde Konuk Breakdown of academic impact, for papers by Masatoshi Sakurai Breakdown of academic impact, for papers by Ernesta Audisio Breakdown of academic impact, for papers by José L. Ochoa-Bayona Breakdown of academic impact, for papers by Kun Soo Lee Breakdown of academic impact, for papers by Alfredo Molteni Breakdown of academic impact, for papers by Elham Askari Breakdown of academic impact, for papers by María Collado Breakdown of academic impact, for papers by A. Insunza
Rankless by CCL
2026